Ratings by H.C. Wainwright (Emily Bodnar)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2026 | Sana Biotechnology | SANA | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2026 | Arcellx Inc. | ACLX | Downgrade | Neutral (Buy) |
64.11 (114.33) |
78.33% | Details | |
| 2/17/2026 | Autolus Therapeutics plc | AUTL | New Coverage | Buy (N/A) |
1.40 (1.51) |
7.86% | Details | |
| 2/12/2026 | NovoCure Ltd. | NVCR | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2026 | Imunon | IMNN | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2026 | Rapt Therapeutics | RAPT | Downgrade | Neutral (Buy) |
35.10 (58.02) |
65.3% | Details | |
| 1/13/2026 | NovoCure Ltd. | NVCR | Maintain | Buy (Buy) |
|
Details | ||
| 1/8/2026 | Ventyx Biosciences Inc | VTYX | Downgrade | Neutral (Buy) |
13.73 (14.00) |
1.97% | Details | |
| 1/5/2026 | Genelux Corp. | GNLX | Maintain | Buy (N/A) |
|
Details | ||
| 12/24/2025 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2025 | vTv Therapeutics | VTVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2025 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Geron Corporation | GERN | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/11/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2025 | Geron Corporation | GERN | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/9/2025 | Agios Pharma | AGIO | Maintain | Buy (Buy) |
|
Details | ||
| 12/5/2025 | Atossa Genetics | ATOS | Maintain | Buy (Buy) |
|
Details | ||
| 12/2/2025 | NovoCure Ltd. | NVCR | Maintain | Buy (Buy) |
|
Details | ||
| 11/20/2025 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Artiva Biotherapeutics | ARTV | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2025 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Sana Biotechnology | SANA | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Context Therapeutics | CNTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Ventyx Biosciences Inc | VTYX | Upgrade | Buy (Neutral) |
8.09 (14.00) |
73.05% | Details | |
| 10/31/2025 | NovoCure Ltd. | NVCR | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2025 | Ventyx Biosciences Inc | VTYX | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/20/2025 | Agenus Inc. | AGEN | Maintain | Buy (Buy) |
|
Details | ||
| 10/20/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (Buy) |
|
Details | ||
| 10/20/2025 | Agios Pharma | AGIO | Maintain | Buy (Buy) |
|
Details | ||
| 10/17/2025 | Artiva Biotherapeutics | ARTV | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2025 | AnaptysBio | ANAB | Maintain | Buy (Buy) |
|
Details | ||
| 10/14/2025 | Briacell Therapeutics | BCTX | Maintain | Buy (Buy) |
|
Details | ||
| 10/14/2025 | Senti Biosciences, Inc. | SNTI | New Coverage | Buy (N/A) |
1.68 (0.96) |
-42.86% | Details | |
| 10/7/2025 | Atossa Genetics | ATOS | Maintain | Buy (Buy) |
|
Details | ||
| 10/7/2025 | Arcus Biosciences | RCUS | Maintain | Buy (Buy) |
|
Details | ||
| 10/6/2025 | TG Therapeutics | TGTX | New Coverage | Buy (N/A) |
36.71 (29.27) |
-20.27% | Details | |
| 9/30/2025 | NovoCure Ltd. | NVCR | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2025 | IO Biotech | IOBT | Downgrade | Neutral (Buy) |
1.58 (0.30) |
-81.01% | Details | |
| 9/22/2025 | SAB Biotherapeutics | SABS | Maintain | Buy (Buy) |
|
Details | ||
| 9/10/2025 | Agenus Inc. | AGEN | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2025 | Atossa Genetics | ATOS | Maintain | Buy (Buy) |
|
Details | ||
| 9/5/2025 | Agios Pharma | AGIO | Maintain | Buy (Buy) |
|
Details | ||
| 9/3/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (Buy) |
|
Details | ||
| 8/27/2025 | Briacell Therapeutics | BCTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | MiNK Therapeutics | INKT | Upgrade | Buy (Neutral) |
15.32 (10.28) |
-32.9% | Details | |
| 8/12/2025 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | NextCure Inc. | NXTC | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2025 | NovoCure Ltd. | NVCR | Maintain | Buy (Buy) |
|
Details | ||
| 7/23/2025 | Genelux Corp. | GNLX | Maintain | Buy (Buy) |
|
Details | ||
| 7/22/2025 | SAB Biotherapeutics | SABS | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2025 | MiNK Therapeutics | INKT | Downgrade | Neutral (Buy) |
40.61 (15.32) |
-62.28% | Details | |
| 7/14/2025 | MiNK Therapeutics | INKT | Maintain | Buy (Buy) |
|
Details | ||
| 7/11/2025 | Briacell Therapeutics | BCTX | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2025 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2025 | Agenus Inc. | AGEN | Maintain | Buy (Buy) |
|
Details | ||
| 7/7/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2025 | NovoCure Ltd. | NVCR | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2025 | Femasys Inc. | FEMY | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2025 | Sana Biotechnology | SANA | Maintain | Buy (Buy) |
|
Details | ||
| 6/20/2025 | Imunon | IMNN | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2025 | Ventyx Biosciences Inc | VTYX | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/17/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (Buy) |
|
Details | ||
| 6/16/2025 | Arcellx Inc. | ACLX | Maintain | Buy (Buy) |
|
Details | ||
| 6/11/2025 | Artiva Biotherapeutics | ARTV | New Coverage | Buy (N/A) |
2.08 (5.74) |
175.96% | Details | |
| 6/10/2025 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2025 | AnaptysBio | ANAB | Upgrade | Buy (Neutral) |
23.52 (55.41) |
135.59% | Details | |
| 6/4/2025 | Agenus Inc. | AGEN | Upgrade | Buy (Neutral) |
5.00 (2.95) |
-41% | Details | |
| 6/3/2025 | Arcus Biosciences | RCUS | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2025 | NovoCure Ltd. | NVCR | Maintain | Buy (Buy) |
|
Details | ||
| 5/30/2025 | Purple Biotech Ltd. | PPBT | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (Buy) |
|
Details | ||
| 5/22/2025 | Rapt Therapeutics | RAPT | New Coverage | Buy (N/A) |
0.89 (35.10) |
3843.82% | Details | |
| 5/14/2025 | SAB Biotherapeutics | SABS | New Coverage | Buy (N/A) |
1.88 (3.79) |
101.6% | Details | |
| 5/14/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | Genelux Corp. | GNLX | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2025 | NovoCure Ltd. | NVCR | Maintain | Buy (Buy) |
|
Details | ||
| 4/24/2025 | Sana Biotechnology | SANA | Maintain | Buy (Buy) |
|
Details | ||
| 4/23/2025 | Briacell Therapeutics | BCTX | Maintain | Buy (Buy) |
|
Details | ||
| 4/16/2025 | ransCode Therapeutics Inc | RNAZ | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2025 | vTv Therapeutics | VTVT | New Coverage | Buy (N/A) |
15.80 (35.41) |
124.11% | Details | |
| 4/1/2025 | Connect Biopharma Holdings Ltd | CNTB | Maintain | Buy (Buy) |
|
Details | ||
| 3/31/2025 | Genelux Corp. | GNLX | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2025 | Femasys Inc. | FEMY | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2025 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Nkarta Inc. | NKTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2025 | Atossa Genetics | ATOS | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2025 | Genelux Corp. | GNLX | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2025 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2025 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (Buy) |
|
Details | ||
| 3/18/2025 | Agenus Inc. | AGEN | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/18/2025 | Sana Biotechnology | SANA | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2025 | NextCure Inc. | NXTC | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2025 | Femasys Inc. | FEMY | Maintain | Buy (Buy) |
|
Details | ||
| 3/12/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (Buy) |
|
Details | ||
| 3/12/2025 | Geron Corporation | GERN | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/6/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | IO Biotech | IOBT | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2025 | AnaptysBio | ANAB | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/28/2025 | Imunon | IMNN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2025 | Geron Corporation | GERN | Downgrade | Neutral (Buy) |
2.37 (1.53) |
-35.44% | Details | |
| 2/26/2025 | Arcus Biosciences | RCUS | Upgrade | Buy (Neutral) |
10.24 (22.11) |
115.92% | Details | |
| 2/25/2025 | MiNK Therapeutics | INKT | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2025 | Agios Pharma | AGIO | New Coverage | Buy (N/A) |
35.22 (27.48) |
-21.98% | Details | |
| 2/19/2025 | Arcus Biosciences | RCUS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2025 | AnaptysBio | ANAB | Maintain | Neutral (N/A) |
|
Details | ||
| 2/4/2025 | AnaptysBio | ANAB | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/4/2025 | Briacell Therapeutics | BCTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Sana Biotechnology | SANA | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Acelyrin Inc | SLRN | Maintain | Neutral (N/A) |
|
Details | ||
| 12/19/2024 | ransCode Therapeutics Inc | RNAZ | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2024 | AnaptysBio | ANAB | Downgrade | Neutral (Buy) |
23.09 (23.52) |
1.86% | Details | |
| 12/11/2024 | Acelyrin Inc | SLRN | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/11/2024 | Olema Pharmaceuticals | OLMA | Maintain | Buy (Buy) |
|
Details | ||
| 12/4/2024 | Femasys Inc. | FEMY | Maintain | Buy (Buy) |
|
Details | ||
| 12/3/2024 | NovoCure Ltd. | NVCR | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2024 | Briacell Therapeutics | BCTX | Maintain | Buy (Buy) |
|
Details | ||
| 11/29/2024 | Agenus Inc. | AGEN | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/26/2024 | Imunon | IMNN | Maintain | Buy (Buy) |
|
Details | ||
| 11/15/2024 | Genelux Corp. | GNLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2024 | Acelyrin Inc | SLRN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/13/2024 | Agenus Inc. | AGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/13/2024 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2024 | Sana Biotechnology | SANA | Maintain | Buy (Buy) |
|
Details | ||
| 11/8/2024 | Imunon | IMNN | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | NextCure Inc. | NXTC | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Atossa Genetics | ATOS | Maintain | Buy (Buy) |
|
Details | ||
| 11/5/2024 | Sana Biotechnology | SANA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Geron Corporation | GERN | New Coverage | Buy (N/A) |
4.25 (2.37) |
-44.24% | Details | |
| 10/31/2024 | NovoCure Ltd. | NVCR | Maintain | Buy (Buy) |
|
Details | ||
| 10/24/2024 | Olema Pharmaceuticals | OLMA | Maintain | Buy (Buy) |
|
Details | ||
| 10/21/2024 | Arcus Biosciences | RCUS | New Coverage | Neutral (N/A) |
18.44 (10.24) |
-44.47% | Details | |
| 10/16/2024 | Ventyx Biosciences Inc | VTYX | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/16/2024 | NovoCure Ltd. | NVCR | Upgrade | Buy (Neutral) |
17.78 (13.04) |
-26.66% | Details | |
| 10/15/2024 | Jasper Therapeutics | JSPR | Maintain | Buy (Buy) |
|
Details | ||
| 10/9/2024 | MiNK Therapeutics | INKT | Maintain | Buy (Buy) |
|
Details | ||
| 10/3/2024 | Briacell Therapeutics | BCTX | Maintain | Buy (Buy) |
|
Details | ||
| 9/24/2024 | Ventyx Biosciences Inc | VTYX | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/24/2024 | Context Therapeutics | CNTX | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2024 | Purple Biotech Ltd. | PPBT | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | Briacell Therapeutics | BCTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (Buy) |
|
Details | ||
| 9/12/2024 | Briacell Therapeutics | BCTX | Maintain | Buy (Buy) |
|
Details | ||
| 9/12/2024 | Femasys Inc. | FEMY | Maintain | Buy (Buy) |
|
Details | ||
| 9/6/2024 | ransCode Therapeutics Inc | RNAZ | Maintain | Buy (Buy) |
|
Details | ||
| 9/6/2024 | Connect Biopharma Holdings Ltd | CNTB | Maintain | Buy (Buy) |
|
Details | ||
| 9/3/2024 | IO Biotech | IOBT | Maintain | Buy (Buy) |
|
Details | ||
| 8/19/2024 | Purple Biotech Ltd. | PPBT | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Jasper Therapeutics | JSPR | Maintain | Buy (Buy) |
|
Details | ||
| 8/14/2024 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Acelyrin Inc | SLRN | Downgrade | Neutral (Buy) |
4.76 (2.27) |
-52.31% | Details | |
| 8/9/2024 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Sana Biotechnology | SANA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Context Therapeutics | CNTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2024 | Imunon | IMNN | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2024 | NovoCure Ltd. | NVCR | Maintain | Neutral (N/A) |
|
Details | ||
| 7/22/2024 | AnaptysBio | ANAB | New Coverage | Buy (N/A) |
33.70 (55.41) |
64.42% | Details | |
| 7/18/2024 | Agenus Inc. | AGEN | Downgrade | Neutral (Buy) |
17.73 (5.00) |
-71.8% | Details | |
| 7/12/2024 | Purple Biotech Ltd. | PPBT | Maintain | Buy (Buy) |
|
Details | ||
| 7/11/2024 | Context Therapeutics | CNTX | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2024 | Atossa Genetics | ATOS | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2024 | Agenus Inc. | AGEN | Maintain | Buy (Buy) |
|
Details | ||
| 6/28/2024 | Nkarta Inc. | NKTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/13/2024 | Ventyx Biosciences Inc | VTYX | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/22/2024 | Acelyrin Inc | SLRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Imunon | IMNN | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Acelyrin Inc | SLRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | Context Therapeutics | CNTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2024 | Jasper Therapeutics | JSPR | New Coverage | Buy (N/A) |
24.52 (1.38) |
-94.37% | Details | |
| 5/3/2024 | NovoCure Ltd. | NVCR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/17/2024 | Connect Biopharma Holdings Ltd | CNTB | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2024 | Genelux Corp. | GNLX | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Imunon | IMNN | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Acelyrin Inc | SLRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2024 | NovoCure Ltd. | NVCR | Maintain | Neutral (N/A) |
|
Details | ||
| 3/26/2024 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | Context Therapeutics | CNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | NextCure Inc. | NXTC | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Connect Biopharma Holdings Ltd | CNTB | New Coverage | Buy (N/A) |
1.18 (2.48) |
110.17% | Details | |
| 2/29/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | NovoCure Ltd. | NVCR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/12/2024 | Atossa Genetics | ATOS | New Coverage | Buy (N/A) |
0.94 (4.53) |
381.91% | Details | |
| 1/16/2024 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2024 | Sana Biotechnology | SANA | Upgrade | Buy (Neutral) |
6.32 (3.15) |
-50.16% | Details | |
| 12/26/2023 | Gracell Biotechnologies Inc | GRCL | Downgrade | Neutral (Buy) |
6.19 (10.25) |
65.59% | Details | |
| 11/29/2023 | NovoCure Ltd. | NVCR | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2023 | Genelux Corp. | GNLX | New Coverage | Buy (N/A) |
11.10 (2.71) |
-75.59% | Details | |
| 11/22/2023 | Purple Biotech Ltd. | PPBT | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Ventyx Biosciences Inc | VTYX | Downgrade | Neutral (Buy) |
14.09 (8.09) |
-42.58% | Details | |
| 11/1/2023 | Context Therapeutics | CNTX | Upgrade | Buy (N/A) |
1.06 (3.12) |
194.34% | Details | |
| 10/25/2023 | ransCode Therapeutics Inc | RNAZ | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2023 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2023 | Briacell Therapeutics | BCTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2023 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2023 | Acelyrin Inc | SLRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2023 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2023 | Acelyrin Inc | SLRN | New Coverage | Buy (N/A) |
27.12 (4.76) |
-82.45% | Details | |
| 8/31/2023 | Purple Biotech Ltd. | PPBT | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2023 | NovoCure Ltd. | NVCR | Downgrade | Neutral (Buy) |
29.77 (17.78) |
-40.28% | Details | |
| 8/15/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2023 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2023 | DICE Therapeutics | DICE | Downgrade | Neutral (Buy) |
46.44 (47.55) |
2.39% | Details | |
| 6/7/2023 | NovoCure Ltd. | NVCR | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2023 | Lantern Pharma Inc. | LTRN | New Coverage | Neutral (N/A) |
4.90 (2.70) |
-44.9% | Details | |
| 5/12/2023 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | NovoCure Ltd. | NVCR | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | Sana Biotechnology | SANA | New Coverage | Neutral (N/A) |
5.47 (3.15) |
-42.41% | Details | |
| 3/30/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2023 | Context Therapeutics | CNTX | Downgrade | Neutral (Buy) |
0.66 (3.12) |
372.73% | Details | |
| 3/17/2023 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2023 | NovoCure Ltd. | NVCR | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2022 | Context Therapeutics | CNTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Gracell Biotechnologies Inc | GRCL | New Coverage | Buy (N/A) |
2.63 (10.25) |
289.73% | Details | |
| 12/2/2022 | SQZ Biotechnologies | SQZ | Downgrade | Neutral (Buy) |
1.78 (0.44) |
-75.28% | Details | |
| 11/21/2022 | IO Biotech | IOBT | New Coverage | Buy (N/A) |
2.89 (1.58) |
-45.33% | Details | |
| 11/11/2022 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2022 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2022 | SQZ Biotechnologies | SQZ | New Coverage | Buy (N/A) |
2.82 (0.44) |
-84.4% | Details | |
| 10/17/2022 | Purple Biotech Ltd. | PPBT | New Coverage | Buy (N/A) |
1.98 (4.78) |
141.41% | Details | |
| 10/11/2022 | DICE Therapeutics | DICE | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2022 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (N/A) |
|
Details | ||
| 9/1/2022 | Ventyx Biosciences Inc | VTYX | New Coverage | Buy (N/A) |
20.40 (14.00) |
-31.37% | Details | |
| 8/10/2022 | MiNK Therapeutics | INKT | New Coverage | Buy (N/A) |
1.32 (40.61) |
2976.52% | Details | |
| 7/18/2022 | DICE Therapeutics | DICE | New Coverage | Buy (N/A) |
15.94 (47.55) |
198.31% | Details | |
| 6/9/2022 | Olema Pharmaceuticals | OLMA | Upgrade | Buy (Neutral) |
4.00 (21.55) |
438.75% | Details | |
| 6/7/2022 | ransCode Therapeutics Inc | RNAZ | New Coverage | Buy (N/A) |
1.76 (9.60) |
445.45% | Details | |
| 5/16/2022 | NovoCure Ltd. | NVCR | New Coverage | Buy (N/A) |
65.24 (13.04) |
-80.01% | Details | |
| 4/25/2022 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2022 | Celsion Corp | CLSN | New Coverage | Buy (N/A) |
3.48 (1.96) |
-43.68% | Details | |
| 3/8/2022 | Nkarta Inc. | NKTX | New Coverage | Buy (N/A) |
9.69 (2.50) |
-74.2% | Details | |
| 2/28/2022 | Olema Pharmaceuticals | OLMA | New Coverage | Neutral (N/A) |
4.60 (21.55) |
368.48% | Details | |
| 2/14/2022 | Briacell Therapeutics | BCTX | New Coverage | Buy (N/A) |
7.56 (3.86) |
-48.94% | Details | |
| 2/2/2022 | Context Therapeutics | CNTX | New Coverage | Buy (N/A) |
2.14 (3.12) |
45.79% | Details |
